These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20719221)

  • 1. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.
    Gold MS; McIntyre P
    Sex Health; 2010 Sep; 7(3):320-4. PubMed ID: 20719221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low rates of free human papillomavirus vaccine uptake among young women.
    Moore GR; Crosby RA; Young A; Charnigo R
    Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadrivalent HPV vaccination reactions--more hype than harm.
    Douglas RJ
    Aust Fam Physician; 2009 Mar; 38(3):139-42. PubMed ID: 19283255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the nurse immuniser in implementing and maintaining the National Human Papillomavirus 'Cervical Cancer' Vaccine rollout through a school-based program in Victoria.
    Kent H; Heffernan ME; Silvers J; Moore E; Garland SM
    Sex Health; 2010 Sep; 7(3):391-3. PubMed ID: 20719232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience.
    Heffernan ME; Garland SM; Kane MA
    Sex Health; 2010 Sep; 7(3):383-90. PubMed ID: 20719231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'It's a logistical nightmare!' Recommendations for optimising human papillomavirus school-based vaccination experience.
    Robbins SC; Bernard D; McCaffery K; Skinner SR
    Sex Health; 2010 Sep; 7(3):271-8. PubMed ID: 20719214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models of cervical screening in the era of human papillomavirus vaccination.
    Canfell K
    Sex Health; 2010 Sep; 7(3):359-67. PubMed ID: 20719228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students.
    Chelimo C; Wouldes TA; Cameron LD
    Sex Health; 2010 Sep; 7(3):394-6. PubMed ID: 20719233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
    Block SL; Brown DR; Chatterjee A; Gold MA; Sings HL; Meibohm A; Dana A; Haupt RM; Barr E; Tamms GM; Zhou H; Reisinger KS
    Pediatr Infect Dis J; 2010 Feb; 29(2):95-101. PubMed ID: 19952863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
    Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
    [No Abstract]   [Full Text] [Related]  

  • 16. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine: recommendations, issues and controversies.
    Fisher R; Darrow DH; Tranter M; Williams JV
    Curr Opin Pediatr; 2008 Aug; 20(4):441-5. PubMed ID: 18622201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.
    Souayah N; Michas-Martin PA; Nasar A; Krivitskaya N; Yacoub HA; Khan H; Qureshi AI
    Vaccine; 2011 Jan; 29(5):886-9. PubMed ID: 20869467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.